Endpoints News 14. Feb. 2026 Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
FierceBiotech 13. Feb. 2026 With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech 12. Feb. 2026 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Endpoints News 11. Feb. 2026 Prasad overruled vaccine review team, office director on Moderna flu shot
FierceBiotech 11. Feb. 2026 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Endpoints News 10. Feb. 2026 Moderna accuses FDA of shifting standard as agency refuses flu shot review
FierceBiotech 30. Jan. 2026 Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech 23. Jan. 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
FierceBiotech 20. Jan. 2026 Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years